Characterization of triglyceride rich lipoproteins with very light density by ultracentrifugation and agarose gel electrophoresis using triglyceride- and cholesterol-staining

Annals of Clinical and Laboratory Science

Volumn 33, Issue 2, 2003, Pages 167-178

  Hidaka, Hiroya ^a,c   Tozuka, Minoru ^b   Meyer, Barbara ^b   Yamauchi, Kazuyoshi ^a   Sugano, Mitsutoshi ^a   Nakabayashi, Tetsuo ^a   Katsuyama, Tsutomu ^c  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apo B 48; Chylomicron; Chylomicron remnant; Hypertriglyceridemia; VLDL remnant

Indexed keywords

APOLIPOPROTEIN B100; CHOLESTEROL; CHYLOMICRON; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

AGAR GEL ELECTROPHORESIS; ANALYTIC METHOD; AQUEOUS SOLUTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; HUMAN; HYPERTRIGLYCERIDEMIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; STAINING; TRIACYLGLYCEROL BLOOD LEVEL; ULTRACENTRIFUGATION;

CHOLESTEROL; CHYLOMICRONS; ELECTROPHORESIS, AGAR GEL; HUMANS; HYPERLIPOPROTEINEMIAS; LIPOPROTEINS, VLDL; TRIGLYCERIDES; ULTRACENTRIFUGATION;

EID: 0038120838     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991;11:2-14.
2. Cooper AD. Hepatic uptake of chylomicron remnants. J Lipid Res 1997;38:2173-2192.
3. Krauss RM. Atherogenicity of triglyceride-rich lipoproteins. Am J Cardiol 1998;26:13B-17B.
4. Marcoux C, Hopkins PN, Wang T, Leary ET, Nakajima K, Davignori J, Cohn JS. Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state. J Lipid Res 2000;41:1428-1436.
5. Twickler TB, Dallinga-Thie GM, Zelissen PM, Koppeschaar HP, Erkelens DW. The atherogenic plasma remnant-like particle cholesterol concentration is increased in the fasting and postprandial state in active acromegalic patients. Clin. Endocrinol 2001;55:69-75.
6. Chapman MJ. Comparative analysis of mammalian plasma lipoproteins. (part A: overview) (Segrest JP, Albers JJ, Eds) Meth Enzymol 1986;128:70-143.
7. Eisenberg S. Plasma lipoprotein conversions. (part B: metabolism of plasma lipoproteins) (Segrest JP, Albers JJ, Eds) Meth Enzymol 1986;129:347-366.
8. Steiner G, Poapst ME, Shumak SL, Foster DM. Metabolism of the apolipoprotein B-containing lipoproteins. (part B: metabolism of plasma lipoproteins) (Segrest JP, Albers JJ, Eds) Meth Enzymol 1986;129:395-420.
9. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoprotein in human serum. J Clin Invest 1955;34:1345-1353.
10. Hatch FT, Lees RS. Practical methods for plasma lipoprotein analysis. Adv Lipid Res 1968;6:1-68.
11. Tallis GA, Shephard MD, Whiting MJ. Lipoprotein profiling by high performance gel chromatography. Clin Chim Acta 1994;228:171-179.
12. Okazaki M, Itakura H, Shiraishi K, Hara I. Serum lipoprotein measurement: liquid chromatography and sequential floatation (ultracentrifugation) compared. Clin Chem 1983;29:768-773.
13. Noble RP. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res 1968;9:693-700.
14. Hulley SB, Cook SG, Wilson WS, Nichaman MZ, Hatch FT, Lindgren FT. Quantitation of serum lipoproteins by electrophoresis on agarose gel: standardization in lipoprotein concentration units (mg/100 ml) by comparison with analytical ultracentrifugation. J Lipid Res 1971;12: 420-433.
15. Campos E, Nakajima K, Tanaka A, Havel RJ. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoprotein isolated from human blood plasma with a monoclonal antibody to apolipoprotein B- 100. J Lipid Res 1992;33:369-380.
16. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H, Campos E. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta 1993;223: 53-71.
17. Levy RI. Cholesterol, lipoproteins, apoproteins, and heart disease: Present status and future prospects. Clin Chem 1981;27:653-662.
18. Hidaka H, Tozuka M, Hidaka E, Yamauchi K, Ohta H, Honda T, Katsuyama T. Characterization of an apolipoprotein E3 variant (Arg 145>His) associated with mild hypertriglyceridemia. Ann Clin Lab Sci 2001;31:163-170.
19. Marcoux C, Michel T, Nakajima K, Davignon J, Jeffrey SC. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients. J Lipid Res 1999;40: 636-647.
20. Schreuder PC, Twickler TB, Wang T, Nakajima K, Erkelens DW, Dallinga-Thie GM. Isolation of remnant particles by immunoseparation: a new approach for investigation of postprandial lipoprotein metabolism in normolipidemic subjects. Atherosclerosis. 2001;157:145-150.
21. Wang T, Nakajima K, Leary ET, Warnick GR, Cohn JS, Hopkins PN, Wu LL, Cilla DD, Zhong J, Havel RJ. Ratio of remnant-like particles-cholesterol to serum total triglycerides is an effective alternative to ultracentrifugal and electrophoretic methods in the diagnosis of familial type III hyperlipoproteinemia. Clin Chem 1999;45: 1981-1987.
22. Park Y, Damron BD, Miles JM, Harris WS. Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion. Lipids 2001;36:115-120.
23. Mahley RW, Ji ZS. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apaolipoprotein E. J Lipid Res 1999;40:1-16.
24. Mahley RW, Huang Y, Rail SC Jr. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes. J Lipid Res 1999; 40:1933-1949.
25. Sata T, Estrich DL, Wood PD, Kinsell LW. Evaluation of gel chromatography for plasma lipoprotein fractionation. J Lipid Res 1970;11:331-340.
26. Nauck M, Winkler K, Marz W, Wieland H. Quantitative determination of high-, low-, and very-low-density lipoproteins and lipoprotein (a) by agarose gel electrophoresis and enzymatic cholesterol staining. Clin Chem 1995;41: 1761-1767.
27. Contois JH, Gillmor RG, Moore RE, Contois LR, Macer JL, Wu AH. Quantitative determination of cholesterol in lipoprotein fractions by electrophoresis. Clin Chim Acta 1999;282:1-14.
28. Sata T, Havel RJ, Jones AL. Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans. J Lipid Res 1972;13:757-768.
29. Okazaki M, Usui S, Tada N, Nakano T, Nakajima K. Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in RLP-cholesterol profiles by HPLC. Clin Chim Acta 2000;296:135-149.
30. Hultin M, Olivecrona T. Conversion of chylomicrons into remnants. Atherosclerosis 1998;141:25-29.
31. Mahley RW, Innerrarity TL, Rail SC Jr, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984;25:1277-1294.
32. Jialal I. A practical approach to the laboratory diagnosis of dyslipidemia. Clin Chem 1996;106:128-138.
33. Bjorkegren J, Karpe F, Milne RW, Hamsten A. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma. J Lipid Res 1998;39:1412-1420.